Resmed's total assets for Q1 2026 were $8.31B, an increase of 1.64% from the previous quarter. CH:RME total liabilities were $2.19B for the fiscal quarter, a -0.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.